Stereotaxis logo
Stereotaxis
STXS | AMEX
Chart Builder DCF Calculator
$0.80
-$0.04 (-5.12%)
At close: Nov 16, 2026, 4:00 PM ET
$0.82
+$0.02 (+2.50%)
After-hours: Nov 16, 2026, 7:10 PM ET

Stereotaxis Company Profile

Company profile explained

Company Profile

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.

Key Executives

Name Position
David Leo Fischel Chief Executive Officer & Chairman
Kimberly R. Peery Chief Financial Officer
Keith Galloway Vice President of Operations
Patricia S. Williams General Counsel & Secretary

Latest SEC Filings

Date Type Title
Aug 19, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Aug 13, 2026 EFFECT Filing
Aug 13, 2026 EFFECT Filing
Aug 13, 2026 424B3 Filing
Aug 13, 2026 424B3 Filing
Aug 12, 2026 10-Q Quarterly Report
Aug 11, 2026 8-K Current Report
Jul 16, 2026 8-K Current Report
Jul 15, 2026 S-3 Filing
Jul 15, 2026 S-3 Filing
View All SEC Filings ➞
Stereotaxis
Stereotaxis logo
Country United States
IPO Date Aug 12, 2004
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 131
CEO David L. Fischel

Contact Details

710 North Tucker Boulevard St. Louis, Missouri 63101 United States

Stock Details

Ticker Symbol STXS
Exchange AMEX
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001289340
CUSIP Number 85916J409
ISIN Number US85916J4094
SIC Code 3845

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.